Hi Jack: re IVIG for DM. The approval of octagam 10% was partly related to a recent study: Aggarwal R et al Medicine 2021 - methods; EULAR 2021 podium OP0007 - results (published in Annals Rheum Dis). Reply
Hi Jack:
re IVIG for DM.
The approval of octagam 10% was partly related to a recent study: Aggarwal R et al Medicine 2021 - methods; EULAR 2021 podium OP0007 - results (published in Annals Rheum Dis).